Life Sciences BC 2026-27 Board Announcement

Skip to Content News Archives Economy Defence Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Defence Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Defence Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeBusiness Wire News ReleasesPMN Press ReleasesThis section is The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Business Wire Life Sciences BC 2026-27 Board AnnouncementAuthor of the article:VANCOUVER, British Columbia — Life Sciences BC (LSBC) is pleased to announce its Board of Directors following its Annual General Meeting (AGM) on October 15, 2026. The Board of Directors is comprised of life sciences leaders dedicated to driving forward the growth of life sciences in British Columbia and represent diverse perspectives across the sector.THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountBoard Members and ObserversLSBC announced the following Board Members who were re-elected as Director for a 3-year term: Rajveer Hundal, Partner, PwC Canada; Lana Janes, Chief Scientific Officer, CPDC (Centre for Probe Development and Commercialization); David Poon, Co-Founder & Head of Corporate Development​, DCx Biotherapeutics; Scott Phillips, President, Starfish Medical; and Peter Zandstra, VP, Research and Innovation​, University of British Columbia.This advertisement has not loaded yet, but your article continues below.At the Board Meeting following the AGM, Joseph Garcia, Partner, Blake, Cassels & Graydon LLP, and Roger Kuypers, Partner, Fasken, Martineau, Dumoulin LLP received renewed one-year appointments as Board Observers.Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againThe full slate of LSBC’s Board of Directors is listed below. To learn more about our current board members, please visit our website.LSBC Board Directors – Executive CommitteeBoard Chair: Lana Janes, Chief Scientific Officer, CPDC (Centre for Probe Development and Commercialization)Past Chair: Anne Stevens, Life Sciences Executive (former VP, Business Development, AbCellera)Treasurer: Rajveer Hundal, Partner, PwC CanadaSherry Aulin, Life Sciences Executive Leader (former CFO, Xenon)Kevin Chaplin, CEO, KardiumTom Frohlich, CEO, Jade BiosciencesWendy Hurlburt, President & CEO, Life Sciences BCMichael Martin, Global Biopharmaceutical Executive (former COO, Aurinia)Scott Phillips, President, Starfish MedicalDavid Poon, Co-Founder, Head of Corporate Development, DCx BiotherapeuticsSandra Wong, Senior Manager, Access and Government Affairs, Pfizer CanadaChristina Zacharuk, CEO, Research Universities’ Council of British ColumbiaPeter Zandstra, VP, Research and Innovation, University of British ColumbiaJoseph Garcia, Partner, Blake, Cassels & Graydon LLPRoger Kuypers, Partner, Fasken, Martineau, Dumoulin LLPPast Board Members and ObserverLSBC would like to thank our outgoing Board Directors and Observer for their service and leadership over the past years.Ali Ardakani, Founder & Managing Director, Novateur Ventures, Co-Founder & CEO of Optigo Biotherapeutics, LSBC Board Director for nine years including two as Board ChairSuzanne Gill, Life Sciences Executive, LSBC Board Director for four yearsDavid Helliwell, Co-Founder & Executive Board Chair, Thrive Health, LSBC Board Director for six yearsHector MacKay-Dunn, KC, Senior Partner, Farris, Vaughan, Wills & Murphy LLP, LSBC Board Observer for many yearsLife Sciences BC (LSBC) is a not-for-profit sector association dedicated to advancing British Columbia’s life sciences ecosystem through strategic initiatives at the local, national, and international levels. We drive economic growth in the province by providing leadership, fostering investment and partnerships, collaborating with government, and promoting BC’s world-class life sciences sector.View source version on businesswire.com: Manager, Marketing & CommunicationsThis advertisement has not loaded yet.Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.